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INTRODUCTION
PERCUTANEOUS transluminal coronary angioplasty (PTCA)
and intracoronary thrombolytic therapy have been per-
formed as aggressive reperfusion therapies for acute myo-
cardial infarction (AMI). Both therapies can improve the
fate of ischemic myocardium surrounding the infarct
core, leading to consequent improvements in left ven-
tricular function and long-term survival.1–5 According to
previous studies, clinical outcomes of these therapies are
similar,5 but some authors suggested that PTCA could be
more effective than thrombolytic therapy in treating un-
derlying arteriographic stenoses.4 To discuss the strategy
for treating AMI, evaluation of the efficacy of reperfusion
therapies has become an important issue recently. To
resolve this issue, there are several kinds of conventional
methods including electrocardiography (ECG) and
echocardiography, which are often performed under ex-
ercise or pharmacological stress, and the measurement of
serum cardiac markers such as creatine phosphokinase
(CK).1,6–11 These methods, however, cannot always fully
disclose the underlying cardiac functional status and path-
ological changes. For example, the presence of conduc-
tion disturbances might hinder correct ECG diagnosis in
exercise stress test, while echocardiography tends to un-
derestimate cardiac function.12 Peak blood creatine phos-
phokinase level (pCK) cannot provide any information
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regarding the location of the damaged myocardium, and
its level tends to depend on the sampling time after the
onset.
In view of these facts, single photon emission com-
puted tomography (SPECT) with myocardial perfusion
agents is a better choice for evaluating reperfusion therapy
because it is noninvasive and can give correct information
regarding infarcted area and viable myocardial mass.
Some authors reported that the findings of myocardial
perfusion SPECT were significantly correlated with the
pathological infarct size.13 Furthermore, the recent advent
of labeling kits for Tc-99m labeled myocardial perfusion
agents such as Tc-99m tetrofosmin has enabled emergent
SPECT examination for evaluating the risk area in pa-
tients with AMI. To date, several studies regarding the use
of Tc-99m labeled myocardial perfusion agents in reper-
fusion therapies were reported.5,10,14–17 These studies,
however, employed qualitative or semiquantitative meth-
ods based on the visual scoring or profile curves for the
image analysis. For more objective and quantitative SPECT
evaluation of infarcted myocardium, we introduced a new
quantitative index of salvaged myocardial volume (SMV),
which was based on the functional myocardial volume
calculated from the SPECT images taken before and after
reperfusion therapy. In this feasibility study, the clinical
significance of SMV was investigated using data from
eight patients with AMI.
MATERIALS AND METHODS
Subjects
The subjects consisted of eight patients (five men, three
women; mean age, 60 ± 12 years old) who were admitted
to the Sapporo-Higashi Tokushukai Hospital with AMI.
The diagnoses were based on ECG, echocardiography,
and clinical symptoms such as severe typical chest pain
lasting for at least 30 minutes. After the admission, culprit
arteries were confirmed by coronary angiography (CAG)
and urgent PTCA was performed. No patient had any
history of previous myocardial infarction or other cardiac
diseases. All the patients and their families provided
written informed consent to participate in this study.
Radiopharmaceutical
Tc-99m tetrofosmin was prepared using a kit vial
(Myoview®, Nihon Medi-Physics, Nishinomiya, Japan)
and Tc-99m pertechnetate freshly eluted from a Tc-99m
generator (Meditech®, Nihon Medi-Physics, Nishinomiya,
Japan). Tc-99m labeling of tetrofosmin was performed
immediately after the angiographic confirmation of coro-
nary artery stenoses and the decision to perform urgent
revascularization.
Imaging protocol
Tc-99m tetrofosmin (740 MBq) was injected intrave-
nously before urgent PTCA. About 6 hours after the
PTCA, SPECT data acquisition was performed to obtain
images reflecting the risk area before PTCA using a
rotating dual-headed digital gamma camera system
equipped with low-energy high-resolution collimators
(GCA 7200, Toshiba, Tokyo, Japan). The in-plane spatial
resolution of this system was 20 mm FWHM in the air.
Sixty-four projections over 360-degree were recorded in
a 64 × 64 matrix with an acquisition time of 25 seconds per
each projection, using an energy window of 10% centered
at 140 keV. Two weeks after the first SPECT, the follow-
up SPECT after PTCA was performed using the same
acquisition parameters as used in the first SPECT study.
SPECT image reconstruction was performed on a
dedicated data processing unit (GMS-5500DI, Toshiba,
Japan). Standard filtered back-projection algorithm with-
out attenuation and scatter correction was chosen. A ramp
filter was used after preprocessing with a Butterworth
filter (order 8, cutoff-frequency 0.42 cycle/cm) to recon-
struct transaxial images with 6.9 mm thickness. Oblique
sections including short-axial slices with 1-pixel thick-
ness were then generated by pixel reorientation.
Calculation of myocardial perfusion volume and sal-
vaged myocardial volume
Myocardial perfusion volume (MPV) was defined as a
functional volume that was calculated by integrating the
voxels whose counts were greater than 50% of the maxi-
mum voxel count in the myocardium. Using short-axial
images, a circular region of interest (ROI) surrounding
whole left ventricular myocardium was drawn with a
freehand technique. After confirming that all the left
ventricular myocardial slices were within the ROI, the
maximum voxel count in the myocardium was deter-
mined. Based on the maximum voxel count, MPV was
calculated. SMV was defined as a volume calculated by
subtracting MPV after PTCA from that before PTCA.
Clinical significance of MPV and SMV
To clarify the clinical significance of MPV and SMV,
relationships of MPV to myocardial perfusion and culprit
artery were investigated. MPV and SMV were compared
with the results of visual evaluation of the SPECT images.
Relationships of SMV to the clinical parameters related to
the infarct size, such as pCK and time from the onset of
AMI to reperfusion (RPT), were also investigated.
Relationships of MPV to myocardial perfusion and cul-
prit artery
To investigate the relationship of MPV to myocardial
perfusion, MPV was compared with relative myocardial
uptake of Tc-99m tetrofosmin on a segment basis, using
both pre- and post-PTCA SPECT data. Left ventricular
myocardium was divided into four segments (anterior,
septal, inferior, and lateral segments) based on the four
equal sector regions of interest radially placed on a short-
axial plane. Mean segmental myocardial uptake was
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calculated by dividing mean voxel count of a segment by
the maximum voxel count of the whole myocardium.
Segmental MPV was determined by dividing whole MPV
according to the four sector regions of interest. Correla-
tion between the segmental MPV and the mean segmental
uptake was examined. And to examine whether segmen-
tal decrease in MPV matched up to the territory of the
culprit artery, the subjects were divided into three groups
according to their culprit arteries (LAD, RCA, and LCX).
Segmental MPV from the pre-PTCA SPECT studies was
compared in these three groups.
Relationships of SMV to therapeutic efficacy of PTCA
Therapeutic efficacy of PTCA was assessed visually by
comparing the pre- and post-PTCA SPECT images. Im-
provement on SPECT images was classified into three
grades by a consensus of two nuclear medicine physi-
cians: 0, no improvement; 1, partial improvement; 2,
complete improvement. Correlation between SMV and
the visual grades was examined. As an index of infarct
Fig. 1   This plot shows the correlation between MPV and mean
percentage of uptake to maximum before the PTCA. These two
parameters show a statistically significant correlation (p <
0.0007).
Fig. 2   This plot shows the correlation between MPV and the
mean percentage of uptake to maximum after the PTCA. These
two parameters also show a statistically significant correlation
(p < 0.0009).
size, pCK level was also compared with SMV. Since
RPT is thought to be a major factor affecting the fate
of ischemic myocardium, we investigated whether RPT
was related to SMV. The subjects were divided into two
groups according to RPT: early-reperfusion, RPT < 6
hours; late-reperfusion, RPT > 6 hours. SMV was com-
pared between these two groups.
Statistical analysis
For parametric and nonparametric correlation analyses,
Pearson’s product-moment correlation coefficient and
Spearman’s rank correlation coefficient were calculated
with corresponding p values. To test the between-group
differences, two-sample t-test was used with or without
Satterthwaite’s approximation depending on the equality
of variances. A p value less than 0.05 was considered
statistically significant. If a p value was greater than 0.05
but less than 0.1, a trend toward statistical significance
was noted.
Table 1   Patient characteristics
Patient Age Sex Culprit artery RPT (h) pCK (U/l)
No. 1 64 M LCX segment 11 ; 99% 6.88 2019
No. 2 46 F RCA segment 4AV ; 100% 4.75 2830
No. 3 61 F LAD segment 6 ; 50%
segment 7 ; 100% 6.33 2001
No. 4 85 F RCA segment 1 ; 100% 2.53 1090
No. 5 60 M LCX segment 11 ; 100% 6.83 3377
No. 6 61 M RCA segment 3 ; 100% 1.57 1553
No. 7 46 M LAD segment 6 ; 100% 6.5 6030
No. 8 59 M LCX segment 11 ; 100% 18.25 7000
Abbreviations: RPT = time from the onset of the AMI to reperfusion, pCK = peak creatine phosphokinase,
RCA = right coronary artery, LAD = left anterior descending branch, LCX = left circumflex branch
The characteristics and results of reperfusion therapies were shown in this table. Percutaneous transluminal
coronary angioplasty (PTCA) for these patients had been successful without death or other major complica-
tions.
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RESULTS
Patient profiles are summarized in Table 1. Culprit arter-
ies were LAD, LCX, and RCA in two, three, and three
cases, respectively. In all cases, urgent PTCA resulted in
success without any major complications or death. RPT
ranged from 1.57 to 18.25 hours. In three cases, RPT was
less than 6 hours. Pre-PTCA SPECT studies could be
performed without any significant interference with ur-
gent patient care.
Relationships of MPV to myocardial perfusion and cul-
prit artery
Whole MPV of the left ventricle calculated from pre- and
post-PTCA SPECT studies ranged from 134 to 272 ml
and from 123 to 244 ml. Segmental MPV calculated by
dividing whole MPV according to the four sector ROIs
ranged from 5.8 to 98.5 ml and from 8.1 to 87.6 ml in pre-
and post-PTCA studies. On the other hand, mean segmen-
tal myocardial uptake ranged 53.4% to 73.2% and from
55.0% to 72.9% in pre- and post-PTCA studies. Segmen-
tal MPV from pre- and post-PTCA studies was plotted
against corresponding segmental myocardial uptake in
scatter plots (Figs. 1, 2). There were significant correla-
tions between segmental MPV and segmental myocardial
uptake in both pre- and post-PTCA studies (p < 0.0007
and p < 0.0009).
Mean and SD of the pre-PTCA segmental MPV in the
three groups of culprit artery were expressed in bar graphs
Fig. 3   These bar graphs show each correlation of MPV with the culprit artery. Figure 3A refers to the
anterior segment. Figure 3B to the septal segment, Figure 3C to the inferior segment, and Figure 3D to




Fig. 4   This bar graph shows the correlation of the SMV with the
visual score. These two parameters show a statistically significant
correlation (p < 0.0368).
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for each segment (Fig. 3A–D). Segmental MPV from the
pre-PTCA studies showed a decrease in the segment
corresponding to the territory of the culprit artery. In the
anterior, septal, inferior, and lateral segments, segmental
MPV showed the minimum in the LAD, RCA, and LCX
groups of culprit artery, respectively.
Relationships of SMV to therapeutic efficacy of PTCA
SMV calculated as the difference between post- and pre-
PTCA MPVs ranged from −28 to 46 ml. Grading of
therapeutic efficacy of PTCA by visual comparison of
pre- and post-PTCA SPECT gave the result that two, four,
and two cases were graded as grade 0, 1, and 2. The mean
SMVs in the corresponding visual grades were −22.3 ±
9.81, 18.7 ± 15.0, and 35.0 ± 15.6 ml, respectively (Fig. 4).
There was a significant correlation between SMV and the
visual grade (p < 0.037).
The blood pCK level ranged from 1,090 to 7,000 U/l.
The relationship of SMV to pCK was expressed in a
scatter plot (Fig. 5). Between blood pCK level and SMV,
there was a trend toward a significant inverse correlation
(p < 0.100).
Time from the onset of AMI to reperfusion (RPT) is
summarized in Table 1. In three cases, RPT was less than
6 hours. The mean SMV values of the early-reperfusion
(RPT < 6 hours) and late-reperfusion groups (RPT > 6
hours) were 30.0 ± 14.0 and −6.2 ± 25.5 ml (Fig. 6). There
was a trend toward a significant difference between SMVs
of these two groups (p < 0.068).
DISCUSSION
In evaluation of the therapeutic efficacy of urgent PTCA
in AMI, it is desirable to obtain detailed information of the
risk area that might lapse into eventual infarction unless
effective intervention is implemented. Indirect methods,
such as electrocardiography and echocardiography, have
been playing a major role for this purpose in the routine
clinical setting, although they are not sufficient. With the
advent of Tc-99m myocardial perfusion agents such as
Tc-99m tetrofosmin, it has become possible to grasp the
extent and severity of the risk area directly from myocar-
dial perfusion SPECT images. Quick formulation of Tc-
99m labeled agents injectable on demand and relatively
stable myocardial accumulation that holds myocardial
perfusion at administration have enabled immediate in-
jection on admission and late imaging after the provision
of necessary treatment. These features are essential for the
use of Tc-99m labeled myocardial perfusion agents for
evaluation of the risk area in AMI.
In evaluation of myocardial perfusion SPECT images,
quantitative indexes such as extent and severity scores
based on circumferential curve profiles are useful for
objective evaluation of perfusion abnormality. However,
these indexes depend somewhat on operator’s slice selec-
tion, and do not directly reflect myocardial mass volume.
According to previous studies, some authors used a
polar map to evaluate the defect size in acute myocardial
infarction. But, this method has difficulty evaluating
the affected region. The real defect size is not reflected
correctly on a polar map because the original 3-dimen-
sional myocardial configuration can’t be transformed to a
2-dimensional polar map without spatial distortion. Com-
pared to these indexes, MPV has the advantages of more
objective calculation and direct reflection of absolute
viable myocardial mass volume in principle. To our
knowledge, there is no previous study using MPV as an
objective index, and our method offers enhanced objec-
tivity.
In calculation of MPV, the threshold percentage for
myocardial boundary determination is an important fac-
tor. Some previous studies, using Tc-99m sestamibi as
perfusion agents, reported that a 60% threshold is better.5
But unfortunately, relatively few studies have commented
on the use of Tc-99m tetrofosmin. A 50% threshold
should theoretically be optimal if no scatter and no attenu-
ation exist,5 and some previous studies using Tc-99m
Fig. 5   This plot shows the relationship of SMV and pCK in the
blood. There is a tendency of inverse correlation (p < 0.100).
Fig. 6   This bar graph shows the SMV in the early-reperfusion
group and late-reperfusion group. SMV of the early-reperfusion
group tends to have much more salvaged volume compared with
late-reperfusion group (p < 0.0680).
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tetrofosmin adopted 50% as an appropriate threshold for
evaluating myocardial viability.12,18 We decided the thresh-
old regarding the above-mentioned. However, since MPV
is simply determined by threshold of relative uptake, it
might not reflect the severity of myocardial ischemia. In
this context, mean segmental uptake, which reflects the
severity of ischemia, and segmental MPV were correlated
significantly. This result indicated that MPV could reflect
not only viable myocardial mass volume but also the
severity of ischemia. Furthermore, segmental decrease in
MPV was in good agreement with the territory of the
culprit arteries. These results indicated that MPV could be
used as a quantitative index of viable myocardial mass.
Thus, SMV, which is the difference is MPV between pre-
and post-PTCA, could be a practical quantitative index of
salvaged myocardial mass volume.
In this study, pCK and RPT were used as clinical
parameters that could be related to the therapeutic effi-
cacy of PTCA. However, pCK did not show a significant
correlation with SMV. According to Figure 5, one patient
had a deviated SMV value. This patient had re-PTCA
after this study because of restenosis. In the acquisition of
post-PTCA study, although this patient had neither sub-
jective nor objective symptoms, there is a possibility that
this restenotic lesion might have affected the result. And
the following reasons are also possible. Another determi-
nant of pCK except the quantity of infarcted myocardium
was the period between the onset of AMI and blood
sampling. Moreover, CK includes several isozymes, some
of which are not of cardiac origin. These factors might
have a certain influence on the correlation between pCK
and SMV.
As for RPT, it is not the only factor that determines the
infarcted myocardial mass volume. Both duration and
degree of ischemia could be related to infarcted myocar-
dial mass volume. Considering these circumstances of
pCK and RPT, although a significant correlation or differ-
ence was not obtained with SMV, their trends to signifi-
cance could support the feasibility of SMV as a practical
index of salvaged myocardial mass volume.
Limitations of the study
This study has several limitations that should be men-
tioned. First, the number of subjects was limited to only
eight. This could influence the statistical test results.
Second, attenuation and scatter corrections were not per-
formed in reconstruction of SPECT images. This could
influence the values of MPV and SMV, especially in
inferior segmental ones. Third, we could not perform tests
for evaluating left ventricular function and correlate
functional parameters to MPV and SMV. To resolve this
important issue, gated SPECT study could be useful,
enabling direct comparison of left ventricular function
and SMV.
CONCLUSION
This study has some limitations as mentioned above. But,
compared with other indexes, MPV has an advantage
from a quantitative and objective standpoint in principle.
Furthermore, this study indicates that MPV and SMV are
clinical meaningful indexes. In conclusion, it is possible
that MPV and SMV are useful indexes for estimating
viable myocardium and salvaged myocardium, respec-
tively.
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